605 page 1/2 15 July 2018 Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company/registered scheme/notified foreign passport fund name BLS Pharmaceuticals Limited ACN/ARSN/APFRN ACN 084 464 193 NFPFRN (if applicable) 1.Details of substantial holder...
Ceasing to be a substantial holder
Filed with ASX · · 2 pages · English
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- Becoming a substantial holder
- AGM Date and Director Nominations
- Application for quotation of securities - BLS
- Initial Director's Interest Notice
- Angus Walker Appointed Alternate Director to Edward Myer
Later from BLS Pharmaceuticals
- Quarterly Activities/Appendix 4C Cash Flow Report
- BLS Quarterly Activities Report September 2026 Revised
- Q1 FY2027 Quarterly Activities Update
- Notice of Annual General Meeting/Proxy Form
- Letter to Shareholders re Annual General Meeting
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals